Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

CONMED Reports Q3 2026 Net Income of $19.8 Million

None

CONMED Corporation (NYSE: CNMD) reported third-quarter 2026 net sales of $335.6 million, down 0.7% year over year, and GAAP net income of $19.8 million, compared with $2.9 million a year earlier.

GAAP diluted earnings per share were $0.66, versus $0.09 in the prior-year quarter. The company updated its full-year 2026 net sales guidance to $1.360 billion to $1.366 billion.

  • Third-quarter GAAP basic EPS was $0.66, while diluted EPS was $0.66.
  • Domestic sales declined 11.0%, while international sales increased 13.1%.
  • Organic constant-currency net sales increased 6.7%, excluding strategic exits of GI product offerings.
  • Orthopedic Surgery sales were $148.8 million, up 7.7%; General Surgery sales were $186.7 million, down 6.5%.
  • Full-year adjusted diluted EPS guidance was updated to $4.54 to $4.61.

$CNMD Hedge Fund Activity

We have seen 117 institutional investors add shares of $CNMD stock to their portfolio, and 112 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles